Withdrawal notice to: “Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 2: Experimental validation of the models of expansion, mechanical strength, and in vitro drug release” [Int. J. Pharm. 653 (2024) 123429] - Retracted Article | RetractBase